Guideline outlines recommendations for managing hypertrophic cardiomyopathy, providing new clinical insights.
The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Ommen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: